If you are switching between weekly medications, you should not administer two medications in the same week
Dry or hard stool is often difficult to pass and can be a direct result of the slowed gastric emptying associated with GLP-1 receptor agonists like semaglutide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces mean body weight reductions of 20.9% at 72 weeks by delaying gastric emptying, suppressing ghrelin rebound, and enhancing glucose-dependent insulin secretion
While they can offer antioxidant support and brighten surface-level pigmentation, their effects are limited compared to oral or injectable forms, as glutathione molecules struggle to penetrate deeply into skin layers
Similar content being viewed by others Subjects Key facts Brain cancer cells (including cancer stem cells (CSCs)) from glioblastoma (GBM) and medulloblastoma (MB), rely on high iron uptake and storage to support proliferation, survival, and stemness and thus exhibit an iron addiction
Direct answer: Staying on semaglutide maintains appetite control, while stopping removes that support